The BOLD Infrastructure for Alzheimer’s Act
Thanks to our hardworking advocates across the nation, AIM is leading the way to develop, introduce and grow support for laws like the bipartisan Building Our Largest Dementia (BOLD) Infrastructure for Alzheimer's Act (P.L.115-406). Signed into law in 2018, this critical law is creating an Alzheimer’s public health infrastructure across the country to implement effective Alzheimer’s interventions focused on public health issues such as increasing early detection and diagnosis, reducing risk, and preventing avoidable hospitalizations.
The BOLD Infrastructure for Alzheimer’s Act provides for funding to state, local and tribal public health departments to help them implement these effective Alzheimer’s interventions, established Alzheimer’s and Related Dementias Public Health Centers of Excellence, and increased data analysis and timely reporting on Alzheimer’s, cognitive decline, caregiving and health disparities.
Working with our tireless advocates and bipartisan congressional champions, the Alzheimer’s Impact Movement (AIM) was instrumental in the development, introduction and the passage of the BOLD Infrastructure for Alzheimer’s Act.
Be a Champion in the Fight to End Alzheimer’s
Our voices are stronger together. Help AIM advance legislation to improve the lives of people impacted by Alzheimer’s and all other dementia.
- Share your story with elected officials
- Engage on social media
- Write a letter to the editor
A restrictive Centers for Medicare & Medicaid Services (CMS) policy that only applies to those living with Alzheimer’s disease is blocking access to FDA-approved treatments. CMS must reverse its unprecedented decision that denies Medicare coverage of current and future treatments for Alzheimer’s.
The bipartisan NAPA Reauthorization Act and the Alzheimer’s Accountability and Investment Act would build on the progress made over the last decade by continuing to promote rapid research and improve the delivery of clinical care and services for people living with Alzheimer’s.